×
Back to Agenda
Session 3 (Parallel Session) : Can RWE Replace Conventional Clinical Trials in Regulatory Decision-Making?
Session Chair(s)
Ju-Young Shin, PHD
Professor, School of Pharmacy, Sungkyunkwan University, Korea, Republic of
Hyungjin Jung, MD, MBA
Senior Medical Director, Lundbeck Korea, Korea, Republic of
Speaker(s)
Tae Hyun Jung, PHD
Senior Statistical Reviewer, CDER, FDA, United States
Hojoon Lee, DrPH, MD, MPH
Head, JAPAC Data & Analytic Center Epidemiology, Amgen, Korea, Republic of
Sohee Kim, PHD
Executive Officer, Clinical Statistics Team, Yuhan Corporation , Korea, Republic of
So Hee Kim, PHD
Director / Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of
JiYoon Ahn, MD, MPH
Engagement Manager, Real World Insights, RWS, IQVIA Korea, Korea, Republic of
Kyu-Pyo Kim, MD, PHD
Professor, Department of Oncology, Asan Medical Center, Korea, Republic of
Have an account?